Mr. Beat Up

United Health's done well, yeah.

Now, we haven't introduced the stock you're going to talk about today, but before we get to it, you wanted to do an honorable mention.

Nice.

Now, the way you said that was slightly confusing.

Eucalyptus is the largest digital health company in Australia.

Hims and Hers is the largest in the US and probably the world as a result.

Doesn't believe in this stock.

I own it, so that might come through in today's conversation.

They're a direct-to-consumer healthcare platform.

Telehealth started in 2017 with HIMSS, Men's Health.

Then in 2018, they started HERS, Women's Health.

They have licensed clinicians who can diagnose and prescribe, and then they'll ship things discreetly to people's doors, cut out all of the middlemen and all of the rent-seekers in the American healthcare landscape.

That's the business model.

Today, they've got 2.6 million subscribers.

They're one of the fastest growing healthcare businesses in the US.

But Simon, God, they've been beaten up.

Yeah, they bought a facility in California to compound peptides.

Okay, so if you didn't follow that, it had a massive run up in the last few years and then it's down 60%.

Well, when we do this Mr. Beat Up segment, we like to look at our four-step checklist to think about is an individual stock worth adding to the portfolio?

And question number one, Simon, is does it make a great product or service?